29 mins ago · India
India orders top drugmaker to halt eye medicine production at plant over quality lapses
What's happening
SignalsMonitor is following this as a general story. Channel NewsAsia Latest is the outlet attached so far. The reports are tied to India. The first report grouped here was at 30 Oct 2026, 12:55 UTC. The headline in use is “India orders top drugmaker to halt eye medicine production at plant over quality lapses”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by Channel NewsAsia Latest
India orders top drugmaker to halt eye medicine production at plant over quality lapses
Reported by 1 outlet
- Channel NewsAsia Latest
- Channel NewsAsia LatestIndia orders top drugmaker to halt eye medicine production at plant over quality lapses